KPX Lifescience.Co.Ltd (114450) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.095x

Based on the latest financial reports, KPX Lifescience.Co.Ltd (114450) has a cash flow conversion efficiency ratio of 0.095x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.33 Billion ≈ $2.26 Million USD) by net assets (₩35.13 Billion ≈ $23.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See KPX Lifescience.Co.Ltd (114450) defensive interval to measure how many days the company can operate on defensive assets alone.

KPX Lifescience.Co.Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how KPX Lifescience.Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

KPX Lifescience.Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of KPX Lifescience.Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Murudeshwar Ceramics Limited NSE:MURUDCERA	0.023x
Kingston Resources Ltd AU:KSN	0.081x
U10 SA PA:ALU10	0.340x
Trimegah Karya Pratama Tbk PT JK:UVCR	0.798x
Airan Limited NSE:AIRAN	0.035x
Superdong Fast Ferry Kien Giang JSC VN:SKG	N/A
System and Application Technologies Co. Ltd KQ:060540	0.023x
Rohas Tecnic Bhd KLSE:9741	-0.016x

Annual Cash Flow Conversion Efficiency for KPX Lifescience.Co.Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of KPX Lifescience.Co.Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see how much is KPX Lifescience.Co.Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩35.75 Billion ≈ $24.23 Million	₩525.49 Million ≈ $356.12K	0.015x	+42.84%
2023-12-31	₩35.95 Billion ≈ $24.37 Million	₩370.02 Million ≈ $250.76K	0.010x	+111.90%
2022-12-31	₩52.64 Billion ≈ $35.67 Million	₩-4.55 Billion ≈ $-3.08 Million	-0.086x	-896.27%
2021-12-31	₩56.30 Billion ≈ $38.15 Million	₩611.38 Million ≈ $414.33K	0.011x	-66.11%
2020-12-31	₩59.37 Billion ≈ $40.23 Million	₩1.90 Billion ≈ $1.29 Million	0.032x	-54.41%
2019-12-31	₩60.36 Billion ≈ $40.90 Million	₩4.24 Billion ≈ $2.87 Million	0.070x	-22.75%
2018-12-31	₩59.11 Billion ≈ $40.06 Million	₩5.38 Billion ≈ $3.64 Million	0.091x	-0.57%
2017-12-31	₩62.09 Billion ≈ $42.08 Million	₩5.68 Billion ≈ $3.85 Million	0.091x	-20.17%
2016-12-31	₩61.66 Billion ≈ $41.79 Million	₩7.07 Billion ≈ $4.79 Million	0.115x	+16.09%
2015-12-31	₩56.90 Billion ≈ $38.56 Million	₩5.62 Billion ≈ $3.81 Million	0.099x	+24.53%
2014-12-31	₩51.53 Billion ≈ $34.92 Million	₩4.09 Billion ≈ $2.77 Million	0.079x	--

About KPX Lifescience.Co.Ltd

KQ:114450 Korea Pharmaceuticals

Market Cap

$22.01 Million

₩32.48 Billion KRW

Market Cap Rank

#24829 Global

#1766 in Korea

Share Price

₩2165.00

Change (1 day)

-4.20%

52-Week Range

₩2065.00 - ₩4045.00

All Time High

₩20587.50